Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Gastritis Treatment Companies

Gastritis is a condition characterized by inflammation of the stomach lining, and its treatment involves a combination of lifestyle changes, medications, and sometimes surgery. Various pharmaceutical and healthcare companies focus on developing and manufacturing medications and therapies for gastritis treatment.

Gastritis Treatment Market

Latest Gastritis Treatment Companies Updates:

AstraZeneca PLC (UK): Launched its Nexium 40 mg chewable tablets in the US in July 2023, offering a convenient and patient-friendly option for managing acid reflux and esophagitis associated with gastritis.

Takeda Pharmaceutical Company Limited (Japan): Received FDA approval for its Vonoprazan (TAK-438) for treating erosive esophagitis, expanding its portfolio of drugs targeting upper gastrointestinal conditions like gastritis.

Microbiotix, Inc. (US): Presented successful preliminary clinical trial results for its investigational live bacterial therapeutic, MBX8866, in treating H. pylori infection, a major cause of gastritis.

Reddy's Laboratories Ltd. (India): Partnered with US-based biopharmaceutical company, Ocugen, Inc., to develop and commercialize biosimilars of PPIs, increasing access to affordable treatment options in emerging markets.

Bio-Rad Laboratories, Inc. (US): Showcased its advanced diagnostic tests for H. pylori and other gastric disorders at a recent medical conference, highlighting the importance of accurate diagnosis for effective gastritis treatment.

List of Gastritis Treatment Key companies in the market:

Abbott Laboratories

AstraZeneca PLC

Novartis AG

Microbiotix, Inc

Reddy’s Laboratories

Lupin Ltd

Perrigo Pharmaceutical

Cipla Inc.

Pfizer Inc.

Gastritis Treatment Market Highlights:

Gastritis Treatment Market Size

Gastritis Treatment Market Trends

Gastritis Treatment Market Analysis

Gastritis Treatment Market Share

Gastritis Treatment Market Highlights:

Gastritis Treatment Market Trends

Gastritis Treatment Market Analysis

Gastritis Treatment Market Share

Gastritis Treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.